Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea

• Sean M. O'Cathail,
• Richard Adams,
• Maria A. Hawkins,
• David Sebag-Montefiore,
• Corrie A.M. Marijnen,
• Emmanouil Fokas

Affiliations

Sean M. O'Cathail

School of Cancer Sciences, University of Glasgow & Beatson Cancer Centre, Glasgow, UK

Richard Adams

Velindre Cancer Centre, Cardiff, UK

Maria A. Hawkins

Department of Medical Physics and Bioengineering, University College London, UK

David Sebag-Montefiore

Leeds Institute of Medical Research, University of Leeds, UK

Corrie A.M. Marijnen

Dept of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, NL, Netherlands; Dept of Radiation Oncology, Leiden University Medical Center, Leiden, NL, Leiden University Medical Center, Netherlands

Emmanouil Fokas

Address: Department of Radiotherapy and Oncology, University of Frankfurt Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.; Department of Radiotherapy of Oncology, University of Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site: Frankfurt, Germany; Frankfurt Cancer Institute (FCI), Germany